Literature DB >> 22253319

Competing risks in epidemiology: possibilities and pitfalls.

Per Kragh Andersen1, Ronald B Geskus, Theo de Witte, Hein Putter.   

Abstract

BACKGROUND: In studies of all-cause mortality, the fundamental epidemiological concepts of rate and risk are connected through a well-defined one-to-one relation. An important consequence of this relation is that regression models such as the proportional hazards model that are defined through the hazard (the rate) immediately dictate how the covariates relate to the survival function (the risk).
METHODS: This introductory paper reviews the concepts of rate and risk and their one-to-one relation in all-cause mortality studies and introduces the analogous concepts of rate and risk in the context of competing risks, the cause-specific hazard and the cause-specific cumulative incidence function.
RESULTS: The key feature of competing risks is that the one-to-one correspondence between cause-specific hazard and cumulative incidence, between rate and risk, is lost. This fact has two important implications. First, the naïve Kaplan-Meier that takes the competing events as censored observations, is biased. Secondly, the way in which covariates are associated with the cause-specific hazards may not coincide with the way these covariates are associated with the cumulative incidence. An example with relapse and non-relapse mortality as competing risks in a stem cell transplantation study is used for illustration.
CONCLUSION: The two implications of the loss of one-to-one correspondence between cause-specific hazard and cumulative incidence should be kept in mind when deciding on how to make inference in a competing risks situation.

Mesh:

Year:  2012        PMID: 22253319      PMCID: PMC3396320          DOI: 10.1093/ije/dyr213

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  5 in total

1.  Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.

Authors:  Ronald B Geskus
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

2.  A nonidentifiability aspect of the problem of competing risks.

Authors:  A Tsiatis
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

Review 3.  Pseudo-observations in survival analysis.

Authors:  Per Kragh Andersen; Maja Pohar Perme
Journal:  Stat Methods Med Res       Date:  2009-08-04       Impact factor: 3.021

4.  Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified.

Authors:  Nadine Grambauer; Martin Schumacher; Jan Beyersmann
Journal:  Stat Med       Date:  2010-03-30       Impact factor: 2.373

5.  Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  A Gratwohl; J Hermans; J M Goldman; W Arcese; E Carreras; A Devergie; F Frassoni; G Gahrton; H J Kolb; D Niederwieser; T Ruutu; J P Vernant; T de Witte; J Apperley
Journal:  Lancet       Date:  1998-10-03       Impact factor: 79.321

  5 in total
  271 in total

1.  Benzodiazepine-associated delirium in critically ill adults.

Authors:  Irene J Zaal; John W Devlin; Marijn Hazelbag; Peter M C Klein Klouwenberg; Arendina W van der Kooi; David S Y Ong; Olaf L Cremer; Rolf H Groenwold; Arjen J C Slooter
Journal:  Intensive Care Med       Date:  2015-09-24       Impact factor: 17.440

2.  A multi-state model based reanalysis of the Framingham Heart Study: Is dementia incidence really declining?

Authors:  Nadine Binder; James Balmford; Martin Schumacher
Journal:  Eur J Epidemiol       Date:  2019-10-14       Impact factor: 8.082

3.  Horizontal mixture model for competing risks: a method used in waitlisted renal transplant candidates.

Authors:  Katy Trébern-Launay; Michèle Kessler; Sahar Bayat-Makoei; Anne-Hélène Quérard; Serge Briançon; Magali Giral; Yohann Foucher
Journal:  Eur J Epidemiol       Date:  2017-10-30       Impact factor: 8.082

4.  A causal framework for classical statistical estimands in failure-time settings with competing events.

Authors:  Jessica G Young; Mats J Stensrud; Eric J Tchetgen Tchetgen; Miguel A Hernán
Journal:  Stat Med       Date:  2020-01-27       Impact factor: 2.373

5.  Flexible Modeling of the Association Between Cumulative Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Risk of Cancer in Adults With Congenital Heart Disease.

Authors:  Coraline Danieli; Sarah Cohen; Aihua Liu; Louise Pilote; Liming Guo; Marie-Eve Beauchamp; Ariane J Marelli; Michal Abrahamowicz
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

6.  Risk.

Authors:  Stephen R Cole; Michael G Hudgens; M Alan Brookhart; Daniel Westreich
Journal:  Am J Epidemiol       Date:  2015-02-05       Impact factor: 4.897

7.  A competing risks approach to "biologic" interaction.

Authors:  Per Kragh Andersen; Anders Skrondal
Journal:  Lifetime Data Anal       Date:  2015-01-23       Impact factor: 1.588

8.  Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.

Authors:  Marloes G M Derks; Cornelis J H van de Velde; Daniele Giardiello; Caroline Seynaeve; Hein Putter; Johan W R Nortier; Luc Y Dirix; Esther Bastiaannet; Johanneke E A Portielje; Gerrit-Jan Liefers
Journal:  Oncologist       Date:  2019-01-03

9.  A population-based multistate model for diffuse large B-cell lymphoma-specific mortality in older patients.

Authors:  Çağlar Çağlayan; Jordan S Goldstein; Turgay Ayer; Ashish Rai; Christopher R Flowers
Journal:  Cancer       Date:  2019-02-01       Impact factor: 6.860

10.  Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia.

Authors:  Salvatore T Scali; Catherine K Chang; Dan Raghinaru; Michael J Daniels; Adam W Beck; Robert J Feezor; Scott A Berceli; Thomas S Huber
Journal:  J Vasc Surg       Date:  2012-12-12       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.